Targeting 4EBP1/HSP90β/Nrf2 Sensitizes β-Catenin-Mutant Liver Cancer to mTOR Inhibitors Through Ferroptosis
Hepatocellular carcinoma, the most common primary cancer of the liver, may become more vulnerable to treatment through a molecular pathway ...
